ADMA continues to expect to revenues of more than $500 million in 2025 and $625 million in 2026. Net income is projected to exceed $175 million in 2025 and $245 million in 2026.

The Centers for Disease Control and Prevention and the Department of Health and Human Services adopted Aug. 4 the Advisory ...

It’s perfectly fine for patients to conduct online research and follow debates about various vaccines, but ultimately, the right decision is one made between you and your providers.

But it is possible to get the sniffles — or worse — in the summer. Federal data released Friday, for example, shows COVID-19 is trending up in many parts of the country, with emergency department ...

A North Tyneside mum has joined NHS bosses in encouraging those expecting a baby to get protected against a raft of ...

Inpatient mortality and adverse outcomes were significantly more likely among adults hospitalized with RSV infection vs seasonal influenza.

Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery.

New study finds RSV hospitalisation rates in older adults across Europe are 2.2–6.4 times higher than earlier estimates.

The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to ...

RNA expert Jeff Coller spoke with Live Science about the future of mRNA vaccines in the United States in the aftermath of ...

Robert F. Kennedy Jr. claims to support “safe, effective vaccines” — but yanking $500 million of research funding on 22 key ...

The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...